GLP-1 Medications in India: A Complete 2025 Guide
Ozempic, Wegovy, Mounjaro — what's available in India, what's CDSCO-approved, what each costs, and how to get prescribed without a 3-month clinic wait.
Dr. Priya Desai
ALTRcare Medical Team
Complete Guide to GLP-1 Medications in India
If you're considering GLP-1 therapy for weight loss in India, this guide covers everything you need to know: what's available, what's approved, costs, and how to access it.
CDSCO-Approved GLP-1s in India (2025)
- Semaglutide (Ozempic, Wegovy): Approved for diabetes and weight loss
- Tirzepatide (Mounjaro, Zepbound): Recently approved for weight loss
Availability & Cost Breakdown
Semaglutide (0.5–1 mg weekly): ₹6,500–8,500/month | Tirzepatide (2.5–15 mg weekly): ₹15,000–25,000/month
How to Get Prescribed
Traditional route: Book a clinic appointment → Wait 3–6 weeks → In-person consultation → Bloodwork → Prescription
ALTRcare route: Online quiz (2 min) → Doctor call (same day) → Bloodwork at home → Prescription + medication in 2–4 days
What You Need to Know
- GLP-1s are not steroids or crash diets — they're prescription medications that work with your body's hormones
- You'll experience reduced hunger, not starvation
- Results are sustained as long as you're on the medication
- Most people tolerate it well with minimal side effects
Ready to take action?
Start your personalized weight loss plan with a free doctor consultation.